
浏览全部资源
扫码关注微信
目的 分析β受体阻滞剂联合胺碘酮在冠心病伴发心律失常中的应用价值及安全性。方法 选取2021年1月至2023年1月在我院收治的冠心病伴发心律失常154例,按照分层抽样法将患者分为对照组、研究组,各77例。对照组行胺碘酮治疗,研究组行β受体阻滞剂联合胺碘酮治疗。比较两组患者临床指标。结果 治疗后研究组发作频次、持续时间低于对照组;治疗后研究组LVEF高于对照组、LVESD以及LVEDD低于对照组;治疗后研究组血清炎性因子水平低于对照组;治疗后研究组BNP及CK-MB水平低于对照组;对照组治疗效果低于研究组;对照组不良反应高于研究组(P<0.05)。结论 对冠心病伴发心律失常患者给予胺碘酮结合β受体阻滞剂治疗,能够显著改善患者心功能,抑制炎性因子对机体造成的损害,临床疗效较好且不良反应较低,安全性高。
Voutilainen Ari,Brester Christina,Kolehmainen Mikko,Tuomainen TomiPekka.Epidemiological analysis of coronary heart disease and its main risk factors: are their associations multiplicative, additive, or interactive?[J].Annals of medicine,2022.
van Kleef Laurens A,Lu Zuolin,Ikram M Arfan,de Groot Natasja M S,Kavousi Maryam,de Knegt Robert J.LIVER STIFFNESS, BUT NOT FATTY LIVER DISEASE, IS ASSOCIATED WITH ATRIAL FIBRILLATION: THE ROTTERDAM STUDY.[J].Journal of hepatology,2022.
Jung Ki Tae,Bapat Aneesh,Kim Young Kug,Hucker William J,Lee Kichang.Therapeutic hypothermia for acute myocardial infarction: a narrative review of evidence from animal and clinical studies.[J].Korean journal of anesthesiology,2022.
Li Siyi,Wang Jinan,Yan Yan,Zhang Zekun,Gong Wei,Nie Shaoping.Clinical Characterization and Possible Pathological Mechanism of Acute Myocardial Injury in COVID-19[J].Frontiers in Cardiovascular Medicine,2022.
Dam Veerle,OnlandMoret N Charlotte,Burgess Stephen,Chirlaque MariaDolores,Peters Sanne A E,Schuit Ewoud,Tikk Kaja,Weiderpass Elisabete,OliverWilliams Clare,Wood Angela M,Tjønneland Anne,Dahm Christina C,Overvad Kim,BoutronRuault MarieChristine,Schulze Matthias B,Trichopoulou Antonia,Ferrari Pietro,Masala Giovanna,Krogh Vittorio,Tumino Rosario,Matullo Giuseppe,Panico Salvatore,Boer Jolanda M A,Verschuren W M Monique,Waaseth Marit,Sánchez Pérez Maria José,Amiano Pilar,Imaz Liher,MorenoIribas Conchi,Melander Olle,Harlid Sophia,Nordendahl Maria,Wennberg Patrik,Key Timothy J,Riboli Elio,Santiuste Carmen,Kaaks Rudolf,Katzke Verena,Langenberg Claudia,Wareham Nicholas J,Schunkert Heribert,Erdmann Jeanette,Willenborg Christina,Hengstenberg Christian,Kleber Marcus E,Delgado Graciela,März Winfried,Kanoni Stavroula,Dedoussis George,Deloukas Panos,Nikpay Majid,McPherson Ruth,Scholz Markus,Teren Andrej,Butterworth Adam S,van der Schouw Yvonne T.Genetically determined reproductive aging and coronary heart disease: a bidirectional two-sample Mendelian Randomization.[J].The Journal of clinical endocrinology and metabolism,2022.
Hasbani R. Natalie,Ligthart Symen,Brown R. Michael,Heath S. Adam,Bebo Allison,Ashley E. Kellan,Boerwinkle Eric,Morrison C. Alanna,Folsom R. Aaron,Aguilar David,de Vries S. Paul.American Heart Association’s Life’s Simple 7: Lifestyle Recommendations, Polygenic Risk, and Lifetime Risk of Coronary Heart Disease[J].Circulation,2022.
Liu Mingxuan,Wu Ying.Role of Mitophagy in Coronary Heart Disease: Targeting the Mitochondrial Dysfunction and Inflammatory Regulation[J].Frontiers in Cardiovascular Medicine,2022.
Podadera-Herreros Alicia,Alcala-Diaz Juan F.,Gutierrez-Mariscal Francisco M.,Jimenez-Torres Jose,Cruz-Ares Silvia de la,Arenas-de Larriva Antonio P.,Cardelo Magdalena P.,Torres-Peña Jose D.,Luque Raul M.,Ordovas Jose M.,Delgado-Lista Javier,Lopez-Miranda Jose,Yubero-Serrano Elena M..Long-term consumption of a mediterranean diet or a low-fat diet on kidney function in coronary heart disease patients: The CORDIOPREV randomized controlled trial[J].Clinical Nutrition,2022.
Esler Murray.Pivotal role of the sympathetic nerves of the human heart in mental stress responses and triggered cardiovascular catastrophes[J].Autonomic Neuroscience: Basic and Clinical,2022.
Guo Yan,Zhang Cui,Ye Tianxin,Chen Xiuhuan,Liu Xin,Chen Xiaoli,Sun Yazhou,Qu Chuan,Liang Jinjun,Shi Shaobo,Yang Bo.Pinocembrin ameliorates arrhythmias in rats with chronic ischaemic heart failure.[J].Annals of medicine,2021.
Ramachandran Hadassah Joann,Jiang Ying,Tam Wilson Wai San,Yeo Tee Joo,Wang Wenru.Effectiveness of home-based cardiac telerehabilitation as an alternative to Phase 2 cardiac rehabilitation of coronary heart disease: a systematic review and meta-analysis.[J].European journal of preventive cardiology,2021.
Bhandari Binita,Kanderi Tejaswi,Yarlagadda Keerthi,Qureshi Mehreen,Komanduri Saketram.Coronary vasospasm as an etiology of recurrent ventricular fibrillation in the absence of coronary artery disease: a case report[J].Journal of Community Hospital Internal Medicine Perspectives,2021.
成红丽.艾司洛尔联合胺碘酮治疗急性心肌梗死并心律失常的效果及对远期预后的影响[J].基层医学论坛,2023(17).
孙旭杜,董梅,张姗.达格列净联合胺碘酮治疗2型糖尿病合并阵发性房颤的疗效及对左心房功能及左心耳容积的影响[J].湖南师范大学学报(医学版),2023(01).
孙铭睿,许轶洲.螺内酯联合胺碘酮预防心房颤动射频消融术后复发的研究进展[J].中国现代医生,2023(05).
刘艳鑫,董长江,邹剑,陈力,舒亚民,何绪成,吴攀.基于FAERS数据库的胺碘酮相关呼吸系统不良事件信号挖掘研究[J].药物流行病学杂志,2023(02).
娄轶群,朱敏,陈子茵.稳心颗粒配合胺碘酮治疗阵发性心动过速临床研究[J].新中医,2023(03).
迪丽热巴·吐尔逊,杨春波,丁琼莉,于湘友.β受体阻滞剂阻断TLR4炎症通路减轻脓毒症心肌损伤的研究[J].中华急诊医学杂志,2022(10).
徐彦娜,张彦芬,吴红群,郭浩楠,冀花.自拟定心汤联合美托洛尔治疗冠心病心律失常的临床分析[J].贵州医药,2022(08).
高东方,谭慧琼,刘少帅,刘晓宁,郭潇,朱俊,吕思奇,莫然,于丽天.β受体阻滞剂在心力衰竭患者中的应用现状调查[J].中华心力衰竭和心肌病杂志,2022(02).
黄洁,江海英.酒石酸美托洛尔联合胺碘酮治疗冠心病伴快速性心律失常患者的临床疗效及其安全性[J].临床合理用药杂志,2022(09).
刘睦胜,晏景红,王冬莉.血清胆红素、糖化血红蛋白水平与老年冠心病合并2型糖尿病患者冠脉病变程度的相关性[J].中国老年学杂志,2021(09).
王红霞.胺碘酮联合美托洛尔治疗冠心病合并心律失常临床疗效及不良反应发生率分析[J].中国药物与临床,2021(08).
陈文明,卓名,李伟杰,郭石生,梁东华.美托洛尔联合参松养心胶囊治疗老年冠心病伴快速心律失常的临床研究[J].中西医结合心脑血管病杂志,2021(05).
杜杰,李玉琳,李扬.心血管疾病防治的转化医学研究——青年冠心病精准防治的困境与转化医学研究方案[J].中国动脉硬化杂志,2021(02).
0
Views
66
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621